Correlation of KLF4 and SPARC expression with the clinical characteristics of non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 15, Issue 12, 2012, Pages 720-724

  Zhang, Zhiping ^a,b   Wang, Zhou ^a   Liu, Xiangyang ^a   Shi, Mo ^a   Chen, Gang ^a   Zhang, Bo ^b   Li, Zhe ^b   Song, Liang ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Kr ppel like factor 4; Lung neoplasms; Secreted protein acidic and rich in cysteine

Indexed keywords

KRUPPEL LIKE FACTOR 4; OSTEONECTIN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATIONAL STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR VOLUME;

EID: 84922687055     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2012.12.05     Document Type: Article

References (17)

1. Jemal A, Bray F, Center MM, et al. Global Cancer Statistics. CA Cancer J Clin, 2011, 61(2): 69-90.
2. Shields JM, Christy RJ, Yang VW. Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor or expressed during growth arrest. J Biol Chem, 1996, 271(33): 20009-20017.
3. Xu J, Lu B, Xu F, et al. Dynamic down-regulation of Krüppel-like factor 4 in colorectal adenoma-carcinoma sequence. J Cancer Res Clin Oncol, 2008, 134(8): 891-898.
4. Zhao ZS, Wang YY, Chu YQ, et al. SPARC is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res, 2010, 16(1): 260-268.
5. Wei D, Gong W, Kanai M, et al. Drastic down-regulation of Krüppel-like factor expression is critical in human gastric cancer development and progression. Cancer Res, 2005, 65(7): 2746-2754.
6. Yiu GK, Chan WY, Ng SW, et al. SPARC(secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells. Am J Pathol, 2001,159(2): 609-622.
7. Zhou Q, Hong Y, Zhan Q, et al. Role for Krüppel-like factor 4 in determining the outcome of p53 response to DNA damage. Cancer Res, 2009, 69(21): 8284-8292.
8. Xu J, Lu B, Xu F, et al. Dynamic down-regulation of Krüppel-like factor 4 in colorectal adenoma-carcinoma sequence. J Cancer Res Clin Oncol, 2008, 134(8): 891-898.
9. Segre JA, Bauer C, Fuchs E. KLF4 is a transcription fact or required for establishing the barrier function of the skin. Nat Genet, 1999, 22(4): 356-360.
10. Chen X, Johns DC, Geiman DE, et al. Krüppel-like factor 4 (Gut-enriched Krüppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J Biol Chem, 2001, 276(32): 30423-30428.
11. Yoon HS, Yang VW. Requirement of Krüppel-like factor 4 in preventing entry into mitosis following DNA damage. J Biol Chem, 2004, 279(6): 5035-5041.
12. Zhao W, Hisamuddin IM, Nandan MO, et al. Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene, 2004, 23(2): 395-402.
13. Kos K, Wilding JP. SPARC: a key player in the pathologies associated with obesity and diabetes. Nat Rev Endocrinol, 2010, 6(4): 225-235.
14. Liang JF, Wang HK, Xiao H, et al. Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer. J Exp Clin Cancer Res, 2010, 29: 71.
15. Inoue M, Senju S, Hirata S, et al. Identification of SPARC as a candidate target antigen for immunotherapy of various cancers. Int J Cancer, 2010, 127(6): 1393-1403.
16. Suzuki M, Hao C, Takahashi T, et al. Aberrant methylation of SPARC in human lung cancers. Br J Cancer, 2005, 92(5): 942-948.
17. Zhou Y, Hofstetter WL, He Y, et al. KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression. Cancer Biol Ther, 2010, 9(7): 507-513.